Increased bleeding in HIV-positive haemophiliac patients treated with lopinavir-ritonavir.
Yazdanpanah
Yazdan
Y
Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculté de Médecine de Lille, France.
Viget
Nathalie
N
Cheret
Antoine
A
Guerroumi
Habib
H
Gerard
Yann
Y
Ajana
Faiza
F
Caron
Jacques
J
Mouton
Yves
Y
D000293:Adolescent; D000328:Adult; D004338:Drug Combinations; D005260:Female; D015658:HIV Infections / Q000150:complications*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D015497:HIV-1; D006467:Hemophilia A / Q000150:complications*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D061466:Lopinavir; D008297:Male; D011744:Pyrimidinones / Q000009:adverse effects; D012189:Retrospective Studies; D019438:Ritonavir / Q000009:adverse effects
D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir